We use cookies, including third party cookies, to personalise and optimise your experience when exploring our website. For more detailed information about our cookies, please refer to cookies section in our privacy notice .
If you agree to the use of cookies, please click “Accept”. To manage your cookies settings, please click “Cookies Settings”.

Cookies Settings


With our comprehensive knowledge and deep experience navigating complex healthcare regulations together with our practical understanding of the unique challenges and commercial issues faced by players in this industry, we have been actively assisting our clients in the healthcare and related industry (e.g. healthcare service providers, pharmacies, pharmaceutical companies, medical devices distributors and etc.) on a broad range of issues and helping them achieving their commercial objectives through regulatory conditions with practical solutions and best-in-class service.

Over the past decade or so, our team has represented clients of all sizes ranging from start-ups to leading healthcare service providers and global pharmaceutical companies. Our services include various types of transactions, including merger and acquisitions, joint ventures, internal restructuring, foreign direct investment, fund raising via debts and equity (both within and outside of Thailand), business cooperation and general commercial transactions as well as advice on regulatory compliance and related issues.

Notable transactions include:

  • advising Navis Capital Partners on the acquisition of in N.P. Medical, a licence holder of S-Spine hospital and RMC Clinic

  • advising Linden Capital Partners on (i) its indirect acquisition of the entire equity interest in Suretex, a Thai subsidiary of LifeStyles Healthcare, a global sexual health and wellness platform, as part of its global acquisition of LifeStyles Healthcare, and (ii) its US$200,000,000 syndicated financing for the above acquisition

  • advising the founders of Unison Group, a leading pharmaceutical and healthcare manufacturer and distributor, on a disposal of its entire equity interest in the group's companies to B.Grimm Healthcare

  • advising Principal Healthcare, a subsidiary of PRINC, on its acquisition of the majority interest in Pewdee Clinic, a chain of renowned aesthetic clinics in Thailand

  • advising Sanofi Group with respect to the internal restructuring and business transfer of its subsidiaries in Thailand to spin off its Consumer Healthcare Business as a standalone business unit under Opella Healthcare

  • joint venture between PharmCare Group, an operator of a health tech platform called “PharmCare”, and Humanica

  • advising Principal Capital, one of the leading players in Thailand’s healthcare industry, in connection with the 10% investment by RATCH Group under the General Mandate Scheme

  • acquisition by SGS Capital of Gifted IVF Udonthani Clinic, a company engaging in the operation of In-Vitro Fertilisation (IVF) clinic in Thailand

  • advising PharmCare Group on its commercial contracts with certain qualified pharmacies and other healthcare service providers as well as its partnered insurance companies in relation to its web-based platform called “PharmCare”

  • advising on a joint venture between Principal Capital and its local partners in a company operating PRINC – Srisaket Hospital

  • advising DKSH on its acquisition of the entire distribution operations of scientific and laboratory devices from a group of sellers who are leaders in the distribution of scientific and laboratory devices in Thailand

  • advising on the disposal of an entire interest in Lavida Advanced Fertility and Genetic Centers, which provides premium assisted reproductive technology (ART) services, including in-vitro fertilization (IVF) and egg freezing

  • disposal of an entire equity interest by Asvatanakul Family in Takeda Thailand, a subsidiary of Japanese’s largest pharmaceutical company, Takeda Pharmaceutical, by way of an entire business transfer and sale of shares

  • acquisition by CITIC Capital and Humanwell Healthcare of Thailand’s sexual wellness business of Ansell and related financing

  • acquisition by Principal Capital of a number of hospitals nationwide, including Paknampho Hospital, Sahavej Hospital, Pitsanuvej Hospital, Piyamin Hospital (currently, Princ Hospital Suvarnabhumi) and Virajsilp Hospital

  • acquisition by Paolo Medic, a 99.99 per cent-owned subsidiary of Bangkok Dusit Medical Services (BDMS), of the entire business of Mayo Polyclinic

  • acquisition by BDMS Group of the entire business of a number of hospitals nationwide, including Muangraj Hospital in Ratchaburi, Phuket International Hospital in Phuket, Sanamchan Hospital, Ratanavej Hospital and Ratanavej Children Hospital in Phisanulok

  • disposition by the founders of 75% interest in Accord Corporation to Henry Schein, a Nasdaq listing company and a worldwide distributor of medical and dental supplies including vaccines, pharmaceuticals, financial services and equipment

  • acquisition by BDMS Group of the entire interest in Save Drug Center, a renowned pharmacy chain with a country-wide outlets

  • invitation to tender and repurchase by BDMS of US$124,000,000 Convertible Bondsผ due 2011 issued by it

  • issue and offering by BDMS of US$124,000,000 Convertible Bonds due 2011

  • placement of new shares in Bumrungrad Hospital following the conversion of Convertible Bonds by Bangkok Bank